{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:20:21Z","timestamp":1772806821518,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.leukres.2004.03.016","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T14:54:10Z","timestamp":1090594450000},"page":"1177-1180","source":"Crossref","is-referenced-by-count":35,"title":["Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells"],"prefix":"10.1016","volume":"28","author":[{"given":"H.","family":"Joachim Deeg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Y.Z.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona A.","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie W.","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2004.03.016_BIB1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumor necrosis factor-a. Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.leukres.2004.03.016_BIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(99)00072-5","article-title":"Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes","volume":"140","author":"Mundle","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2004.03.016_BIB3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1046\/j.1365-2141.1998.00920.x","article-title":"Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles","volume":"102","author":"Molldrem","year":"1998","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.leukres.2004.03.016_BIB4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.leu.2402356","article-title":"Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study","volume":"16","author":"Deeg","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2004.03.016_BIB5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/jir.1998.18.871","article-title":"Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes","volume":"18","author":"Reza","year":"1998","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.leukres.2004.03.016_BIB6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2141.2002.03381.x","volume":"117","author":"Maciejewski","year":"2002","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.leukres.2004.03.016_BIB7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7326\/0003-4819-137-3-200208060-00007","article-title":"Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndrome [summary for patients in Ann Intern Med 6 August 2002;137(3):1\u201327]","volume":"137","author":"Molldrem","year":"2002","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.leukres.2004.03.016_BIB8","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2002-09-2867","article-title":"Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome","volume":"101","author":"Steensma","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.016_BIB9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2003.04136.x","article-title":"A pilot study of antithymocyte globulin (ATG) in the treatment of patients with \u2018low-risk\u2019 myelodysplasia","volume":"120","author":"Killick","year":"2003","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.leukres.2004.03.016_BIB10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hemopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.016_BIB11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/0003-4819-126-2-199701150-00003","article-title":"For the Seattle Bone Marrow Transplant Team. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy","volume":"126","author":"Doney","year":"1997","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.leukres.2004.03.016_BIB12","first-page":"3671","article-title":"Report of an international working group to standardize response criteria for myelodysplastic syndromes","volume":"96","author":"Cheson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.016_BIB13","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","article-title":"HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome","volume":"100","author":"Saunthararajah","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.03.016_BIB14","first-page":"265","article-title":"Relationship between response to cyclosporine treatment and HLA-DR in MDS [Japanese]","volume":"43","author":"Okamoto","year":"2002","journal-title":"Rinsho Ketsueki\u2014Japanese J Clin. Hematol"},{"key":"10.1016\/j.leukres.2004.03.016_BIB15","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2002-11-3325","article-title":"A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:57:14Z","timestamp":1585861034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0145212604001225"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.03.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}